# Vivifi Device Safety Evaluation for the Treatment of Benign Prostatic Hyperplasia

> **NCT07745621** · NA · NOT_YET_RECRUITING · sponsor: **Vivifi Medical** · enrollment: 20 (estimated)

## Conditions studied

- Benign Prostatic Hyperplasia

## Interventions

- **DEVICE:** Minimally invasive percutaneous ablation

## Key facts

- **NCT ID:** NCT07745621
- **Lead sponsor:** Vivifi Medical
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09
- **Primary completion:** 2027-02
- **Final completion:** 2028-12
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-08-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07745621

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07745621, "Vivifi Device Safety Evaluation for the Treatment of Benign Prostatic Hyperplasia". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07745621. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*